Kaia Health
Kaia Health is a digital therapeutics company providing clinical-grade mobile therapies for chronic conditions like joint and muscle pain, recently joining Sword Health.
Classification
Profile
Funding
Funding details not yet available.
Delivers best-in-class digital therapies for chronic joint and muscle care, backed by clinical evidence from 11 trials to improve patient health and reduce costs.
Employers, health plans, and individual consumers seeking accessible, high-quality care for chronic conditions.
B2B2C model selling digital therapy solutions to employers and health plans, likely via subscription or per-member pricing.
Direct sales to enterprise clients (employers, health plans) and digital distribution to end-users.
Sword Health (joined early 2026), clinical research institutions for trial validation, and healthcare providers.
Clinical trial execution, R&D for digital therapy platform, sales and marketing to acquire enterprise clients, and technology infrastructure.
Proprietary digital therapy platform, clinical data from 11 trials, 650,000+ user base, and AI capabilities.
Developing and validating digital therapies, conducting clinical trials, acquiring enterprise clients, and scaling user base.
Enterprise sales-led acquisition for B2B clients; self-serve or app-based engagement for end-users.
Competes in digital therapeutics for musculoskeletal care; differentiates via extensive clinical trial evidence and recent integration with Sword Health.
Limited access to effective chronic disease therapy, high healthcare costs for employers, and need for evidence-based digital health solutions.
- Expand Real-World Evidence (RWE) Dashboard - Offer enterprise clients a live analytics portal showing ROI metrics (e.g., reduced workers’
- Launch an RWE reporting module for enterprise dashboards within 3 months · How can Kaia Health leverage its clinical data to negotiate higher reimbursement rates with insurers? · What are the regulatory hurdles for expanding Kaia’s COPD program into the US market?
- Clinical Evidence - Multiple peer-reviewed RCTs show statistically significant pain reduction and functional improvement, lending strong
No investors recorded yet.